Evidence Rating Level: 1 (Excellent) Study Rundown: Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue currently approved to treat type 2 diabetes and is being studied for weight management in diabetes
However, before clinicians recommend antioxidants, randomized controlled trials with sufficient power are necessary to prove the efficacy of antioxidant supplementation in disorders of female reproduction
Gu L, Lu J, Li Q, Wu N, Zhang L, Li H, et al
In particular, specific research lines should be created based on the peptide's action, which would validate a repeatable in vivo study in animals in order to generate repeatable clinical protocols in humans
Coronavirus and PARP expression dysregulate the NAD Metabolome: a potentially actionable component of innate immunity
Clinically reviewed by Adair Anderson, MS, RDN, LDN The brain relies on neurotransmitters to keep everything from mood to digestion running smoothly